© John Wiley & Sons Ltd
Editors-in-Chief: David Morgan, Thomas Permutt and Gerd Rosenkranz
Impact Factor: 1.235
ISI Journal Citation Reports © Ranking: 2015: 45/123 (Statistics & Probability); 208/253 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome David Morgan as one of three Editors-in-Chief of Pharmaceutical Statistics.
David Morgan is a seasoned drug development professional with experience in UK, US, German and French pharmaceutical companies. He has degrees in Mathematics and in Applied Statistics from Oxford University and is a Chartered Mathematician and Chartered Statistician. David was Chairman of PSI (Statisticians in the Pharmaceutical Industry) from 1995 to 1997 and President of EFSPI (European Federation of Statisticians in the Pharmaceutical Industry) from 2001 to 2003.
David joins existing editors Thomas Permutt and Gerd Rosenkranz in the role.
Recently Published Articles
- Accounting for uncertainty in the historical response rate of the standard treatment in single-arm two-stage designs based on Bayesian power functions
Francesca Matano and Valeria Sambucini
Version of Record online: 21 OCT 2016 | DOI: 10.1002/pst.1788
- Estimating the reliability of repeatedly measured endpoints based on linear mixed-effects models. A tutorial
Wim Van der Elst, Geert Molenberghs, Ralf-Dieter Hilgers, Geert Verbeke and Nicole Heussen
Version of Record online: 29 SEP 2016 | DOI: 10.1002/pst.1787